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Abstract
Background: The Streptococcus pyogenes or Group A Streptococcus (GAS) genome encodes three
ABC transporters, namely, FtsABCD, MtsABC, and HtsABC, which share homology with iron
transporters. MtsABC and HtsABC are believed to take up ferric (Fe3+) and manganese ions and
heme, respectively, while the specificity of FtsABCD is unknown.
Results: Recombinant FtsB, the lipoprotein component of FtsABCD, was found to bind Fe3+
ferrichrome in a 1:1 stoichiometry. To investigate whether FtsABCD transports Fe3+ ferrichrome,
GAS isogenic strains defective in lipoprotein gene ftsB and permease gene ftsC were generated, and
the effects of the mutations on uptake of Fe3+ ferrichrome were examined using radioactive 55Fe3+
ferrichrome. FtsB was produced in the wild-type strain but not in the ftsB mutant, confirming the
ftsB inactivation. While wild-type GAS took up 3.6 × 104 Fe3+ ferrichrome molecules per bacterium
per min at room temperature, the ftsB and ftsC mutants did not have a detectable rate of Fe3+
ferrichrome uptake. The inactivation of ftsB or ftsC also decreased 55Fe3+ ferrichrome uptake by
>90% under growth conditions in the case of limited uptake time. Complementation of the ftsB
mutant with a plasmid carrying the ftsB gene restored FtsB production and 55Fe3+ ferrichrome
association at higher levels compared with the parent strain. The inactivation of mtsA and htsA and
Fe-restricted conditions enhanced the production of FtsB and Fe3+ ferrichrome uptake.
Conclusion: The FtsB protein bound Fe3+ ferrichrome, and inactivation of ftsB or ftsC, but not htsA
or  mtsA, diminished Fe3+ ferrichrome uptake, indicating that FtsABCD, but not HtsABC and
MtsABC, is the transporter that takes up Fe3+ ferrichrome in GAS. Fe acquisition systems are
virulence factors in many bacterial pathogens and are attractive vaccine candidates. The elucidation
of the FtsABCD specificity advances the understanding of Fe acquisition processes in GAS and may
help evaluating the GAS Fe acquisition systems as vaccine candidates.
Background
Ferric iron (Fe3+), the stable iron form in an oxidative
environment, has extremely low solubility in water under
physiological conditions, and mammalian hosts thus do
not have sufficient free Fe3+ to support bacterial growth
[1]. The major sources of iron in vivo for bacteria are host
heme-proteins and other iron complexes [1,2]. Many bac-
terial pathogens secrete low-molecular-weight iron chela-
tors called siderophores to assimilate iron from host
environments [3]. Ferrisiderophores formed are then
Published: 14 October 2005
BMC Microbiology 2005, 5:62 doi:10.1186/1471-2180-5-62
Received: 10 September 2005
Accepted: 14 October 2005
This article is available from: http://www.biomedcentral.com/1471-2180/5/62
© 2005 Hanks et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Microbiology 2005, 5:62 http://www.biomedcentral.com/1471-2180/5/62
Page 2 of 11
(page number not for citation purposes)
transported across the cytoplasmic membrane by specific
ATP-binding cassette (ABC) type transporters. ABC trans-
porters consist of a solute-binding protein, a membrane
protein (permease) encoded by one or two genes, and an
ATPase [4]. The solute-binding proteins are located in the
periplasmic space in Gram-negative bacteria and are lipo-
proteins in Gram-positive organisms. Siderophores can be
divided into several types based on chemical structures
[3]. Ferrichrome [5] belongs to the hydroxamate type.
Streptococcus pyogenes or Group A Streptococcus (GAS) is an
important Gram-positive human pathogen causing both
invasive and non-invasive infections [6]. Non-invasive
infections, including pharyngitis, and post-infection
sequelae, such as acute rheumatic fever, rheumatic heart
disease, and glomerulonephritis, result in substantial
morbidity and economic loss globally. Invasive GAS
infections, such as necrotizing fasciitis and streptococcal
toxic shock syndrome, are associated with high mortality
Binding of Fe3+ ferrichrome to FtsB Figure 1
Binding of Fe3+ ferrichrome to FtsB. (A) Co-migration of Fe3+ ferrichrome with FtsB. FtsB (0.3 ml of 0.18 mM) was incu-
bated with 0.9 mM Fe3+ ferrichrome for 20 min at room temperature, loaded onto a Sephadex G-25 column (1.5 × 18 cm), and 
eluted with 20 mM Tris-HCl buffer, pH 8.0. Eluant was collected as fractions of 0.7 ml. A280 and A425 of each fraction were used 
to monitor FtsA and Fe3+ ferrichrome, respectively. (B) MtsA, as a control, did not bind Fe3+ ferrichrome. The experiment was 
performed under the conditions as those in panel A. (C) The absorption spectra of the protein peaks (fraction 9) in panel A 
(solid curve) and panel B (short dashed curve) and free Fe3+ ferrichrome (long dashed curve). The three samples contained 46 
µM FtsB, 45 µM MtsA, and 100 µM Fe3+ ferrichrome, respectively. (D) Co-migration of partially 55Fe-labeled Fe3+ ferrichrome 
with FtsB. Fe3+ ferrichrome contained radioactive 55Fe3+ at 1.1% of total Fe3+. A280 and 55Fe3+ radioactivity of each fraction are 
presented.
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rates. GAS can take up heme from hemoglobin and hap-
toglobin-hemoglobin complexes [7]. Exogenously-sup-
plied heme and host heme proteins (hemoglobin,
myoglobin, and catalase), but not iron-loaded transferrin
and lactoferrin, support in vitro growth of GAS under
iron-restricted conditions [8].
Iron acquisition processes in GAS are poorly understood,
although progress has recently been made by us [9-11]
and other groups [12-14]. GAS genomes [15-17] encode
three ABC transporters, namely, HtsABC [9-11] or SiaABC
[12], MtsABC [13,14], and one encoded by spy0383 to
spy0386  [18] (designated FtsABCD), which are homo-
logues of ABC transporters involved in iron acquisition.
HtsABC and the cell-surface protein Shp [9-12] are
believed to make up the machinery for heme acquisition.
The lipoprotein component MtsA of MtsABC binds Fe3+,
Zn2+, and Cu2+ [13], and MtsABC is important for acquisi-
tion of Mn2+ and Fe3+ [14]. The transcription of ftsABCD is
up-regulated under iron-restricted conditions [18]. How-
ever, recombinant FtsB was heme-free and did not contain
Fe, Mn, or Zn [10]. The specificity of FtsABCD is thus not
known. It is not known whether GAS can use ferrisi-
derophores such as ferric ferrichrome (Fe3+ ferrichrome)
as an iron source.
We found that recombinant FtsB bound  Fe3+ ferrichrome,
suggesting that FtsABCD is involved in the acquisition of
Fe3+ ferrichrome. To test this hypothesis, GAS isogenic
strains defective in lipoprotein gene ftsB and permease
gene ftsC were generated, and the ftsB and ftsC inactiva-
tion dramatically decreased the uptake of Fe3+  ferri-
chrome, indicating that FtsABCD is the transporter that
takes up Fe3+ ferrichrome in GAS.
Results
Binding of Fe3+ ferrichrome by FtsB
The specificity of an ABC transporter is believed to depend
on the binding specificity of its solute binding protein.
Purified recombinant FtsB did not contain free metal ions,
suggesting that FtsABCD does not target free metal ions
[10]. To test whether FtsABCD targets ferrisiderophores,
the ability of FtsB to bind Fe3+ ferrichrome was examined
by gel filtration. FtsB was incubated with excess Fe3+ ferri-
chrome and separated from free Fe3+ ferrichrome by chro-
matography on a Sephadex G-25 column. Fe3+
ferrichrome has an absorption peak at 425 nm and its elu-
tion profile was monitored by measuring A425 of each frac-
tion. The elution profile displayed two A425 peaks (Fig.
1A). One co-migrated with the FtsB peak, which was local-
ized by A280, and the other corresponded to free Fe3+ ferri-
chrome (Fig. 1A). When FtsB was replaced with MtsA in a
control experiment, there was only one A425 peak corre-
sponding to free Fe3+ ferrichrome, and no absorbance at
425 nm was associated with the protein peak (Fig. 1B). To
check whether the species associated with FtsB was Fe3+
ferrichrome, the absorption spectra of the FtsB and MtsA
peaks and free Fe3+ ferrichrome were compared. In addi-
tion to the protein absorption peak at A280, the FtsB sam-
ple had an absorption peak at 425 nm which was identical
to that of free Fe3+ ferrichrome (Fig. 1C). As expected, the
MtsA sample only had the protein peak (Fig. 1C). These
results indicate that FtsB, but not MtsA, bound Fe3+ ferri-
chrome. The FtsB sample was found to have 1.08 Fe3+ fer-
richrome per FtsB molecule on the basis of protein
content and extinction coefficient of Fe3+ ferrichrome at
425 nm, indicating a 1:1 binding stoichiometry.
If FtsB binds Fe3+ ferrichrome, Fe3+ should co-migrate with
the protein on the G-25 column. To test this idea, Fe3+ fer-
richrome containing 1.1% 55Fe3+ of total Fe3+ was used to
repeat the gel filtration experiment, and 55Fe3+ radioactiv-
ity was monitored. As expected, one of two 55Fe3+ peaks
co-migrated with the FtsB peak, and the other peak corre-
sponded to free Fe3+ ferrichrome (Fig. 1D). On the basis of
55Fe3+ percentage of total iron and specific activity and
protein content, the FtsB peak fraction contained 37 µM
FtsB and 36 µM Fe, consistent with the 1:1 binding stoi-
chiometry determined above. These results confirmed
that FtsB binds Fe3+ ferrichrome in a 1:1 molar ratio.
Effects of ftsB, ftsC, mtsA, and htsA inactivation on Fe3+ 
ferrichrome uptake
The binding results described above suggest that FtsABCD
can acquire Fe3+ ferrichrome. To test this hypothesis, ftsB,
ftsC, and mtsA (control) were first inactivated by inser-
tional inactivation (Fig. 2). Inactivation was confirmed by
PCR (Fig. 2C) and DNA sequencing. Western blotting
analysis detected FtsB (Fig. 2D) and MtsA (Fig. 2E) in the
wild-type strain but not in the corresponding mutant
strain. These results indicate that ftsB  and  mtsA  were
indeed inactivated. The ftsB, ftsC, mtsA, and htsA mutants
(construction of the htsA mutant will be described else-
where) and parent strains were compared in the uptake of
55Fe3+ ferrichrome. Pilot experiments indicated that the
wild-type strain could take up 55Fe3+ ferrichrome at both
room temperature (24°C) and 37°C. The uptake was thus
performed at room temperature for convenience. GAS
cells harvested from exponential growth phase were incu-
bated with 0.16 µM 55Fe3+ ferrichrome at room tempera-
ture for 1 h, and 55Fe3+  radioactivity associated with
bacteria was determined. The ftsB and ftsC inactivation
diminished the uptake of Fe3+ ferrichrome (Fig. 3), while
the  mtsA  and  htsA  inactivation did not abolish but
enhanced the uptake. To further examine the uptake of
Fe3+ ferrichrome, 55Fe3+ radioactivity taken up by bacteria
as a function of incubation time was determined. 55Fe3+
radioactivity with wild-type GAS increased linearly with
time up to 30 min with a slope of 153 cpm/min (Fig. 4).
The value of the slope could be translated into an uptakeBMC Microbiology 2005, 5:62 http://www.biomedcentral.com/1471-2180/5/62
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Insertional inactivation of ftsB, ftsC, and mtsA Figure 2
Insertional inactivation of ftsB, ftsC, and mtsA. (A) Schematic showing the arrangement of ftsABCD genes and their neigh-
bors in the MGAS5005 genome. The ftsA, ftsB, and ftsCD genes encode ATP-binding protein, lipoprotein, and permease, 
respectively. The numbers above the other arrows are the spy numbers assigned to the corresponding open reading frames in 
the M1 genome sequence (15). (B) Schematic for insertional gene inactivation. The paired solid or dotted arrows under the 
mutant genome indicate the locations of primers used to confirm the disruption of the gene using PCR and DNA sequencing. 
(C) PCR confirmation of insertional inactivation of ftsB, ftsC, and mtsA. The picture shows agarose gel analysis of PCR reactions 
using mutant (lanes labeled by 1) or wild type (lanes labeled by 2) genomic DNA as template and primers at the locations indi-
cated by the solid arrows under the mutant genome in panel B. (D) Western blot showing the absence of FtsB in the ftsB 
mutant strain (lane 2) and the presence of FtsB in the wild-type (lane 1) and ftsB/pCMVftsB (lane 3) strains. Proteins from 5 × 
108 wild-type cells, 5 × 108 ftsB mutant cells, and 4 × 106 ftsB/pCMVftsB were probed with FtsB-specific mouse antiserum. The 
amount of ftsB/pCMVftsB cells used was 1/125 of that of the wild-type cells. (E) Western blot showing the presence of MtsA in 
the wild-type strain (lane1) and the absence of MtsA in the mtsA mutant strain (lane 2). Proteins from 6 × 106 wild-type cells 
and 3 × 108 mtsA mutant cells were probed with MtsA-specific mouse antiserum.
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rate of 3.6 × 104 Fe3+ ferrichrome molecules per min per
wild-type GAS bacterium. In contrast, the ftsB and ftsC
mutants did not have a detectable rate of Fe3+ ferrichrome
uptake (Fig. 4). The rate of uptake in the mtsA mutant was
2.6 times as that in the parent strain (Fig. 4). These results
indicate that FtsABCD, not MtsABC and HtsABC, medi-
ates the uptake of Fe3+ ferrichrome.
Complementation
To test whether the effect of the ftsB inactivation on the
uptake of Fe3+ ferrichrome was due to the absence of FtsB,
a complementing strain,ftsB mutant/pCMVftsB, was con-
structed to carry plasmid pCMVftsB with the ftsB gene. The
intensity of FtsB band of the complemented strain in
Western blotting analysis in Fig. 2D was 7/10 of that of the
wild-type strain, and the amount of the complemented
strain cells used was 1/125 of that of the wild-type cells,
indicating that FtsB was produced in ftsB mutant/pCM-
VftsB at a level as 88 times as that in the wild-type strain.
Wild-type, ftsB mutant, and ftsB mutant/pCMVftsB cells
harvested in the exponential growth phase were incubated
with 0.16 µM  55Fe3+ ferrichrome at 24°C for 1 h, and
55Fe3+ radioactivity associated with the bacteria was deter-
mined. 55Fe3+ radioactivity of ftsB mutant/pCMVftsB was
1.9 and 207 times higher than those of the wild-type and
ftsB mutant cells, respectively (Fig. 5), suggesting that in
trans expression of ftsB in the ftsB mutant restored the
association of Fe3+ ferrichrome. The results support that
FtsABCD targets Fe3+ ferrichrome.
Effect of Fe3+ ferrichrome on GAS growth
Since FtsABCD is involved in the uptake of Fe3+ ferri-
chrome, Fe3+ ferrichrome should be an iron source of
GAS. This idea was tested by comparing GAS growth
curves in THY treated with Chelex 100 to remove metal
ions and supplemented with MgCl2 (DTHYMg) in the
absence and presence of Fe3+ ferrichrome. The growth
curve in the presence of 10 µM Fe3+ ferrichrome shifted to
the left by about 40 min compared with that in the
absence of Fe3+ ferrichrome under otherwise identical
conditions. This small but repeatable stimulatory effect
suggests that GAS can use Fe3+ ferrichrome as an iron
source. Fe3+ ferrichrome had similar stimulatory effect on
the growth of the mutants as that on the growth of the
wild type strain, suggesting that either residual uptake of
Fe3+ ferrichrome in the ftsB and ftsC mutants were enough
to induce the stimulatory effect or an additional process
was involved in the uptake of the iron extracted from Fe3+
ferrichrome under the growth conditions.
Effects of ftsB and ftsC inactivations on the uptake of Fe3+ 
ferrichrome under growth conditions
To examine why the stimulatory growth effect of Fe3+ fer-
richrome was still observed in the ftsB and ftsC mutants,
55Fe3+ ferrichrome uptake was examined under growth
conditions. 55Fe3+ ferrichrome was added into the cultures
of wild-type, ftsB, and ftsC  strains at mid-exponential
growth phase, and, 30 min later, 55Fe3+ activity associated
with bacteria was determined. 55Fe3+ radioactivity of ftsB
and ftsC mutant cells were only 7.5% and 5.3% of that of
wild-type cells, respectively (Fig. 6A), indicating that the
ftsB  and ftsC  inactivation also dramatically diminished
uptake of Fe3+  ferrichrome under growth conditions.
However, 55Fe3+ radioactivity of ftsB and ftsC cells grown
for 3 h after the addition of 55Fe3+ ferrichrome were about
50% of that of wild-type cells (Fig. 6B). These results sug-
gest that there could be an additional acquisition process
which could assimilate 55Fe3+ from its ferrichrome com-
plex.
Effects of mtsA and htsA inactivation and Fe-restricted 
conditions on Fe3+ ferrichrome uptake and FtsB 
production
To further examine the factors to affect Fe3+ ferrichrome
uptake, the effects of mtsA and htsA inactivation and Fe-
restricted conditions on FtsB production and Fe3+ ferri-
chrome uptake were investigated. Inactivation of htsA and
mtsA increased  55Fe3+ ferrichrome uptake by more than
100% (Fig. 7A). Wild-type, htsA, and htsA mutant cells
Effects of ftsB, ftsC, mtsA, and htsA inactivation on 55Fe3+ ferri- chrome uptake Figure 3
Effects of ftsB, ftsC, mtsA, and htsA inactivation on 
55Fe3+ ferrichrome uptake. Wild-type and mutant strains 
were grown to OD600 of 0.4 in 10 ml of THY and THY/spec-
tinomycin, respectively. The bacterial pellets were washed 
with 1.0 ml of THY and incubated with 0.16 µM 55Fe3+ ferri-
chrome 1.0 ml of THY at room temperature for 1 h. A tri-
plet of 0.2 ml samples were taken from each mixture, and 
bacteria were pelleted and washed twice with 0.4 ml of THY. 
55Fe3+ radioactivity associated with the bacteria was meas-
ured. Presented are the mean values ± SD of 55Fe3+ radioac-
tivity associated with the bacteria in a representative of three 
experiments.
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harvested from THY containing 2,2'-dipyridyl took up
30%–50% more 55Fe3+ ferrichrome than those from THY
without 2,2'-dipyridyl (Fig. 7A). Western blotting analysis
indicated higher levels of FtsB in the htsA  and  mtsA
mutants compared with the wild-type strain (Fig. 7B).
Higher levels of FtsB were also detected in all strains
grown in the presence of 2,2'-dipyridyl compared with
those grown in the absence of 2,2'-dipyridyl (Fig. 7B). A
control protein, phosphoglycerate kinase (PGK), had sim-
ilar expression levels under all the conditions (Fig. 7B).
The relative intensities of the FtsB bands in the Western
blot correlated well with the relative uptake of 55Fe3+ ferri-
chrome under the same conditions. These results indicate
that FtsB production was enhanced in the htsA and mtsB
mutants and under Fe-restricted conditions, further sup-
porting the role of FtsABCD in Fe acquisition.
Discussion
Evidences from this study indicate that FtsABCD is the
transporter that takes up Fe3+ ferrichrome in GAS. The evi-
dences include the binding of Fe3+ ferrichrome to FtsB, the
effect of the insertional disruption of ftsB or ftsC on uptake
of  55Fe3+  ferrichrome, and the non-involvement of
MtsABC and HtsABC in Fe3+ ferrichrome uptake. Comple-
mentation data of the ftsB  mutant with the ftsB  gene
expressed in trans indicated that the effect of ftsB inactiva-
tion was due to the lack of FtsB. MtsABC [13,14] and
HtsABC [9-12] target free Fe3+ and heme, respectively. The
specificity of the FtsABCD transporter elucidated in this
study resolved the last piece of the puzzle regarding the
roles of ABC transporters in Fe acquisition in GAS.
Uptake time was critical to the effects of ftsB and ftsC inac-
tivation on 55Fe3+ activity associated with bacteria under
growth conditions. The inactivation had a dramatic effect
(>90% decrease in 55Fe3+ activity compared with wild-type
strain) when uptake was performed for only 30 min. This
decrease was reduced to about 50% when uptake was per-
formed for 3 h. Although the reasons for this reduction are
not known, the reduction is unlikely due to the existence
of another transporter for Fe3+ ferrichrome. The other
uptake results are not consistent with the existence of
another Fe3+ ferrichrome transporter. Another possible
reason is that 55Fe3+ ferrichrome exchanged its 55Fe3+ with
another ferric complex in THY, resulting in a non-ferri-
chrome 55Fe3+ complex that could be taken up by another
transporter. GAS has a putative secreted Fe binding pro-
tein (Spy1063). It is not known whether this protein can
extract Fe3+ from Fe3+ ferrichrome.
The transcription of ftsABCD is up-regulated under Fe-
reduced conditions [18]. Consistent with this observa-
tion, Fe-restricted conditions enhanced the production of
FtsB and uptake of Fe3+ ferrichrome, further supporting
the role of FtsABCD in Fe acquisition. Inactivation of htsA
and mtsA also enhanced FtsB production and Fe3+ ferri-
chrome uptake. Apparently, all the three ABC transporters
contributed to Fe3+ acquisition in GAS grown in THY, and
inactivation of either mtsA or htsA might result in lower
intracellular Fe levels and, in turn, enhanced the expres-
sion of ftsABCD. The results also suggest that the expres-
sion of ftsABCD,  htsABC, and mtsABC  is coordinately
regulated.
Some Enterococcus faecium clinical strains do not produce
siderophores but can acquire iron using exogenous
siderophores produced by other bacteria living in the
same habitats [19]. GAS is not known to produce
siderophores, and GAS genomes [15-17] do not have
genes encoding homologues of siderphore-production
systems. We could not detect siderophore production in
GAS under iron-restricted conditions. Therefore, GAS may
The time course of 55Fe3+ ferrichrome uptake for mtsA (open  circles), ftsB (open triangles), and ftsC (solid triangles) mutant  and wild-type (solid circles) GAS strains Figure 4
The time course of 55Fe3+ ferrichrome uptake for 
mtsA (open circles), ftsB (open triangles), and ftsC 
(solid triangles) mutant and wild-type (solid circles) 
GAS strains. Each strain harvested at the mid-exponential 
growth phase from 40 ml culture, washed with 10 ml of 
THY, and incubated with 0.16 µM 55Fe3+ ferrichrome in 4 ml 
of THY at room temperature. A triplet of 0.2 ml samples 
were taken from each mixture at the indicated times, and 
bacteria were immediately pelleted and washed twice with 
0.4 ml of THY. Presented are the mean values ± SD of 55Fe3+ 
radioactivity associated with the bacteria in a representative 
of three experiments.
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not produce siderophors. However, GAS takes up Fe3+ fer-
richrome, suggesting that GAS could acquire Fe3+ by using
siderophores produced by other bacteria in the pharynx
and skin, the noninvasive GAS infection sites.
Fe acquisition systems are virulence factors in many bac-
terial pathogens [20-24] and are attractive vaccine targets
[25-30]. Elucidation of the specificities of the Fe transport-
ers in GAS will facilitate determination of their relative
importance in various infections and choose appropriate
animal infection models to evaluate their efficacy as vac-
cine candidates. For examples, HtsABC could be more
important in invasive GAS infection since heme should be
the Fe source, and FtsABCD could be important in non-
invasive infections because exogenous ferric siderophore
complexes should be available.
In summary, we found that FtsB bound Fe3+ ferrichrome
and that ftsB or ftsC inactivation dramatically decreased
Fe3+ ferrichrome uptake. The results indicate that FtsABCD
is the transporter that acquires Fe3+ ferrichrome in GAS.
Methods
Materials
Iron chelating agent 2,2'-dipyridyl was obtained from
Aldrich. Sephadex G-25, iron-free ferrichrome A from
Ustilago sphaerogena, Chelex 100, and other chemicals
were purchased from Sigma (St. Louis, MO). 55Fe3+-
labeled ferric chloride was purchased from RI Consultants
LLC (Hudson, NH). Purified recombinant FtsB (Spy0385)
and MtsA were prepared as described previously [10,31].
Mouse antisera
Five female outbred CD-1 Swiss mice (4- to 6-week-old)
(Charles River Laboratories, Wilmington, MA) were
immunized subcutaneously with 50 µg of recombinant
FtsB, MtsA, or PGK suspended in 200 µL of saline emulsi-
fied in 44 µL of monophosphoryl lipid A-synthetic treha-
lose dicorynomycolate adjuvant (Corixa, Hamilton, MT).
Mice were boosted at weeks 2 and 4. Immune sera were
collected 5 days after the second boost.
Bacterial strains and growth
Serotype M1 GAS strain MGAS5005 has been described
previously [32]. MGAS5005 and its isogenic mutants were
grown routinely at 37°C in 5% CO2 in Todd-Hewitt broth
(Difco Laboratories, Detroit, MI) supplemented with
0.2% yeast extract (THY). Spectinomycin (150 mg/L) was
added into THY for mutant strains. Iron-restricted condi-
tions were achieved by adding 0.3 mM 2,2'-dipyridyl into
THY and by treating THY with the chelating resin Chelex
100 and supplementing it with 0.4 mM MgCl2
(DTHYMg). Tryptose agar with 5% sheep blood (Becton
Dickinson, Cockeysville, MD) and THY agar were used as
solid media.
Binding of Fe3+ ferrichrome to FtsB
Gel filtration was used to detect the binding of Fe3+ ferri-
chrome to FtsB. FtsB (0.3 ml of 0.18 mM) was incubated
with 0.9 mM Fe3+ ferrichrome for 20 min at room temper-
ature, loaded onto a Sephadex G-25 column (1.5 × 18
cm), and eluted with 20 mM Tris-HCl buffer, pH 8.0. Elu-
ant was collected as fractions of 0.7 ml. The absorbance of
each fraction attributable to protein and Fe3+ ferrichrome
was measured. MtsA as a negative control was similarly
tested for the binding of Fe3+ ferrichrome. The experiment
was repeated with Fe3+ ferrichrome in which 1.1% of total
Fe3+ was  55Fe, and A280 and  55Fe3+ radioactivity of each
fraction were measured. 55Fe3+ radioactivity was measured
using a window of 0–6 keV with a Packard 1500 Tri-Carb
Liquid Scintillation Analyzer.
GAS isogenic mutants
MGAS5005 isogenic mutants defective in ftsC,  ftsB, or
mtsA were generated by insertional inactivation (Fig. 2).
An internal ~400-bp fragment of each gene was PCR-
amplified using MGAS5005 genomic DNA as template
and the primers listed in Table 1. The PCR products were
digested with NcoI and ligated to pFWaad at the NcoI site
to yield suicide plasmids. The orientation of the fragments
was determined by DNA sequencing, and the suicide plas-
mids in which the orientation of the fragments was oppo-
site to that of the aad gene were chosen for generating the
mutants. To obtain pFWaad, the spectinomycin-resistant
gene aad [33] was amplified with primers 5'-AGTGTC-
GACTATAACTAATAACGTAACGTG-3' and 5'-
ACCATGGGAATTCTATAATTTTTTTAATCTGTTATTTA-3'
Complementation of the ftsB mutant Figure 5
Complementation of the ftsB mutant. Plasmid pCM-
VftsB carrying the ftsB gene was introduced into the ftsB 
mutant strain to obtain ftsB/pCMVftsB. The uptake experi-
ment was performed exactly as in Fig. 3. Presented are the 
mean values ± SD of 55Fe3+ radioactivity associated with the 
bacteria.
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and cloned into pFW14 [34] at the SalI and NcoI restric-
tion sites.
Each suicide plasmid was introduced into MGAS5005 by
electroporation at 1.8 kV and 400 Ω. One ml of THY was
added into the sample immediately after electroporation.
The sample was incubated at 37°C for 2 h and plated on
THY agar plates supplemented with 150 mg of spectino-
mycin per liter to select insertional mutants. The plates
were incubated in 5% CO2 at 37°C for two days, and the
colonies obtained were screened by PCR analysis using
the primers listed in Table 1. Gene interruptions were
then confirmed by sequencing the PCR products.
Construction of ftsB-complementing plasmid pCMVftsB
Plasmid pJRS525 [35] was modified to replace the spec-
tinomycin-resistant gene with the chloramphenicol-resist-
ance gene. A 2545-bp fragment without the
spectinomycin-resistant gene was amplified from
pJRS525 with primers 5'-TCGTGGATCC AAGCTTCAC-
CATGG-3' and 5'-AAGAATTCCTTGCATAGACTTTCGT-
CAG-3'. The fragment containing the chloramphenicol-
resistant gene was amplified from pFW14 [23] with prim-
ers 5'-GGAATTCCGGATGCATATGCATG-3' and 5'-GTC-
CGGATCCTCGAGCTCTAGATC-3'. The PCR products
were digested with BamHI and EcoRI and ligated together
to yield plasmid pCMV. A DNA fragment containing ftsB
and its ribosome-binding site was amplified from
MGAS5005 using primers 5'-CGGATCCAATAACTTTAT-
TCTAGGAGAATTAG-3' and 5'-AGGGATCCTTAGTTT-
TCACTTGATAAGATTG-3'. The PCR product was digested
with BamHI and ligated into pCMV at the BamHI site,
yielding pCMVftsB containing ftsB. The cloned gene was
sequenced to rule out spurious mutations and confirm the
desired orientation. The resulting pCMVftsB  was intro-
duced into the ftsB mutant by electroporation, and the
complement strain (designated ftsB/pCMVftsB) was
selected by spectinomycin and chloramphenicol and con-
firmed for the existence of pCMVftsB by colony PCR using
primers 5'-CAATTTCACACAGGAAACAGC-3' (pCMV-spe-
cific) and 5'-AGGGATCCTTAGTTTTCACTTGATAA-
GATTG-3' (ftsB-specific)
Uptake of Fe3+ ferrichrome by GAS
Fe3+ ferrichrome uptake by GAS was monitored using
radioactive  55Fe3+  ferrichrome under non-growth and
growth conditions. Under the non-growth conditions,
wild-type MGAS5005 and its ftsB, ftsC, or mtsA mutant
strains were harvested from the mid-exponential growth
phase (OD600 of 0.4) by centrifugation. The bacterial pel-
lets were washed with 10 ml of THY and resuspended in 1
ml of THY. To prepare 55Fe3+ ferrichrome working solu-
tion, 4.7 nmole 55FeCl3 was incubated with 14.1 nmole
Fe-free ferrichrome A in 50 µL of Tris-HCl for 10 min, and
the complex was diluted with 22 ml of THY. The 1-ml bac-
terial suspensions were mixed with 3 ml of the 55Fe3+ fer-
richrome solution (final Fe3+ ferrichrome concentration
0.16 µM) to initiate the uptake process and rotated in a
10-ml tube from end to end at room temperature. A triplet
of 0.2 ml samples were taken from each mixture at the
indicated times, and bacteria were immediately pelleted
and washed twice with 0.4 ml of THY. For uptake under
growth conditions, 0.16 µM 55Fe3+ ferrichrome was added
into the cultures of wild-type, ftsB, and ftsC strains at early
exponential or mid-exponential growth phase. A triplet of
1-ml culture samples were taken at the indicated times
after the 55Fe3+  ferrichrome addition and treated as
described above. The pellets obtained were resuspended
in 0.2 ml of THY and mixed with 3 ml of scintillation liq-
Effects of ftsB and ftsC inactivation on 55Fe3+ ferrichrome  uptake under growth conditions Figure 6
Effects of ftsB and ftsC inactivation on 55Fe3+ ferri-
chrome uptake under growth conditions. (A) Uptake 
for 30 min. 55Fe3+ ferrichrome (0.16 µM) was added into cul-
tures of the wild-type and mutant strains at 37°C in THY and 
THY supplemented with spectinomycin, respectively, when 
OD600 was 0.3. A triplet of 1 ml samples were taken from 
each culture 30 min later, and bacteria were immediately pel-
leted and washed twice with 0.4 ml of THY. Presented are 
the mean values ± SD of 55Fe3+ radioactivity associated with 
the bacteria. (B) Uptake for 3 h. 55Fe3+ ferrichrome (0.16 µM) 
was added into the wild-type and mutant cultures at 37°C 
when OD600 was 0.2, and, 3 h later, the samples were proc-
essed as in panel A for determination of 55Fe3+ radioactivity.
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Effects of Fe-restricted conditions and mtsA and htsA inactivation on Fe3+ ferrichrome uptake and FtsB production Figure 7
Effects of Fe-restricted conditions and mtsA and htsAinactivation on Fe3+ ferrichrome uptake and FtsB produc-
tion. (A). 55Fe3+ radioactivity uptake by wild-type (wt), ftsB, ftsC, mtsA, and htsA mutant strains grown in THY in the absence 
(solid bars) or presence (slashed bars) of 0.3 mM 2,2'-dipyridyl. The experiment was performed as in Fig. 3. (B) Western blots 
showing the relative levels of FtsB and PGK as a control in the strains grown under the same conditions as in panel A. Proteins 
from 1 × 108 bacteria of each strain were probed with mouse anti-FtsB and anti-PGK antisera. The relative levels of FtsB and 
PGK were obtained by dividing the intensity of each band by the intensity of the FtsB or PGK band of the wild-type strain.
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uid. 55Fe3+ radioactivity associated with the bacteria was
measured as described above.
FtsB and MtsA production
Production of FtsB or MtsA in wild-type and mutant
strains was monitored by Western blotting analysis. To
prepare samples for the analysis, bacteria were harvested
from cultures at the indicated volumes in exponential
phase. The bacterial pellets were washed twice with 1.3 ml
of PBS, resuspended in 100 µl of PBS, and treated with
200 units of mutanolysin at 37°C for 2 h. The samples
were briefly sonicated and mixed with equal volume of 2x
SDS-PAGE loading buffer. Proteins in 10 µl of the samples
were resolved by SDS-PAGE and transferred to nitrocellu-
lose membranes. The proteins were detected by Western
blotting using specific mouse antiserum as previously
described [36].
Other procedures and measurements
Chromosomal DNA was isolated with the Puregene DNA
Isolation kit (Gentra Systems, Minneapolis, MN).
Sequence data were obtained with an ABI 310 automated
DNA sequencer (Applied Biosystems, Inc., Foster City,
CA). Absorbance and optical spectra were obtained with a
SPECTRAmax 384 Plus spectrophotometer (Molecular
Devices, Sunnyvale, CA). Protein concentrations were
determined with the modified Lowry protein assay kit
purchased from Pierce (Rockford, IL) with bovine serum
albumin as a standard. Intensities of the bands in Western
blotting analysis were determined using an AlphaImager
2000 Documentation & Analysis System (Alpha Innotech
Corp.).
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